113 related articles for article (PubMed ID: 7704960)
21. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro.
Atkin SL; Landolt AM; Foy P; Jeffreys RV; Hipkin L; White MC
Clin Endocrinol (Oxf); 1994 Oct; 41(4):503-9. PubMed ID: 7525124
[TBL] [Abstract][Full Text] [Related]
22. p53 gene mutations in pituitary adenomas: rare events.
Levy A; Hall L; Yeudall WA; Lightman SL
Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
[TBL] [Abstract][Full Text] [Related]
23. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
Luque RM; Gahete MD; Valentine RJ; Kineman RD
J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms and protein structures in growth hormone, growth hormone receptor, ghrelin, insulin-like growth factor 1 and leptin in Mehraban sheep.
Bahrami A; Behzadi Sh; Miraei-Ashtiani SR; Roh SG; Katoh K
Gene; 2013 Sep; 527(1):397-404. PubMed ID: 23747407
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues.
Hosoi E; Yokogoshi Y; Hosoi E; Horie H; Sano T; Yamada S; Saito S
Acta Endocrinol (Copenh); 1993 Oct; 129(4):301-6. PubMed ID: 8237246
[TBL] [Abstract][Full Text] [Related]
26. Absence of activating mutations of CXCR4 in pituitary tumours.
Lee YH; Noh TW; Lee MK; Jameson JL; Lee EJ
Clin Endocrinol (Oxf); 2010 Feb; 72(2):209-13. PubMed ID: 19473177
[TBL] [Abstract][Full Text] [Related]
27. A close correlation between the inhibitory effects of insulin-like growth factor-I and SMS 201-995 on growth hormone release by acromegalic pituitary tumours in vitro and in vivo.
Lamberts SW; van Koetsveld P; Hofland L
Clin Endocrinol (Oxf); 1989 Oct; 31(4):401-10. PubMed ID: 2627746
[TBL] [Abstract][Full Text] [Related]
28. DNA and S-phase representation in human growth hormone producing pituitary adenomas.
Hulting AL; Tribukait B; Bergstrand G; Werner S
Acta Endocrinol (Copenh); 1985 Jul; 109(3):295-303. PubMed ID: 4024848
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of acromegalic patients with a good response to octreotide, a somatostatin analogue.
Yang IM; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
Clin Endocrinol (Oxf); 1995 Mar; 42(3):295-301. PubMed ID: 7758235
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide.
Broson-Chazot F; Houzard C; Ajzenberg C; Nocaudie M; Duet M; Mundler O; Marchandise X; Epelbaum J; Gomez De Alzaga M; Schäfer J; Meyerhof W; Sassolas G; Warnet A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):589-98. PubMed ID: 9425399
[TBL] [Abstract][Full Text] [Related]
31. G protein mutations in tumours of the pituitary, parathyroid and endocrine pancreas.
Boothroyd CV; Grimmond SM; Cameron DP; Hayward NK
Biochem Biophys Res Commun; 1995 Jun; 211(3):1063-70. PubMed ID: 7598693
[TBL] [Abstract][Full Text] [Related]
32. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
33. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage.
Lucas T; Astorga R; Catalá M;
Clin Endocrinol (Oxf); 2003 Apr; 58(4):471-81. PubMed ID: 12641631
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of the negative effect of insulin-like growth factor-I on growth hormone gene expression in MtT/S somatotroph cells.
Niiori-Onishi A; Iwasaki Y; Mutsuga N; Oiso Y; Inoue K; Saito H
Endocrinology; 1999 Jan; 140(1):344-9. PubMed ID: 9886844
[TBL] [Abstract][Full Text] [Related]
35. Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan.
Greenman Y; Woolf P; Coniglio J; O'Mara R; Pei L; Said JW; Melmed S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1628-33. PubMed ID: 8636379
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the molecular biology of growth-hormone secreting human pituitary tumours.
Adams EF; Buchfelder M; Hüttner A; Moreth S; Fahlbusch R
Exp Clin Endocrinol; 1993; 101(1):12-6. PubMed ID: 8477819
[TBL] [Abstract][Full Text] [Related]
37. Human pituitary tumours in organ culture with correlation to clinical data.
Anniko M; Wersäll J
Acta Otolaryngol; 1980; 89(3-4):249-57. PubMed ID: 7395496
[TBL] [Abstract][Full Text] [Related]
38. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
Lloyd HM; Jacobi JM; Willgoss DA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
[TBL] [Abstract][Full Text] [Related]
39. The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of
Regazzo D; Losa M; Albiger NM; Terreni MR; Vazza G; Ceccato F; Emanuelli E; Denaro L; Scaroni C; Occhi G
Eur J Endocrinol; 2017 May; 176(5):543-553. PubMed ID: 28179449
[TBL] [Abstract][Full Text] [Related]
40. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
Lamberts SW; Zweens M; Klijn JG; van Vroonhoven CC; Stefanko SZ; Del Pozo E
Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
